New York (December 31st, 2012) - Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX), a biopharmaceutical company engaged in the discovery and development of treatments for human disease, is soaring in mid-day trading today. At last check, LXRX was trading 14.21% higher at $2.18 on volume of 4.14 million, which is significantly above the daily average volume of 877,038.
LXRX has crossed its 200-day moving average as a result of today’s rally. This is a strong bullish signal. The upward momentum could continue if the stock breaks through $2.20 resistance level.
Earlier this month, LXRX had announced that its drug candidate for irritable bowel syndrome received Fast Track status from the FDA.
Find out if LXRX
could maintain the momentum in the very short term by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=LXRX
Radian Group Inc. (NYSE: RDN), a credit enhancement company with a focus on domestic, first-lien residential mortgage insurance, is soaring in mid-day trading today, extending its gains from last week. RDN, in fact, has had an excellent run this month, gaining more than 39%.
The recent rally was sparked after the company announced that it received approval of RMAI subsidiary from Freddie Mac (OTCBB: FMCC) through 2013.
In today’s trading, RDN is up 6.12% to $6.07 on volume of 3.29 million, which is equal to the daily average volume. The stock hit a 52-week high of $6.13 in trading today. Technical indicators for RDN suggest that the rally could continue.
Find out more about RDN by getting the free full report here:
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
WALL STREET REPORT
Leave a comment...